COVID-19 & Psychiatry: A Retrospective Chart Review

Northwestern University65,000 enrolled

Overview

A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.

The goal of this study would be to study the association between use of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression and severity.

Study Type

OBSERVATIONAL

Enrollment

65,000

Conditions

COVID-19

Interventions

No interventionOTHER

Observational study

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Individuals with a positive COVID-19 test between March 15 2020 to November 30 2021 at Northwestern Medicine hospitals. Exclusion Criteria: \-

Locations (1)

Northwester Clinical Research Program

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Hazard Ratio

HR of using psych drugs or having psych diagnosis

Time frame: March 15 2020 to Nov 30 2021

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.